Ascend Wellness : Investor Presentation January 2023

Ascend Wellness Holdings

Q3 2022 Company Presentation

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

This presentation includes forward-looking information and statements (together, "forward-looking statements"), which may include, but are not limited to, the plans, intentions, expectations, estimates, and beliefs of Ascend Wellness Holdings, Inc ("AWH" or the "Company"). Words such as "expects", "continue", "will", "anticipates" and "intends" or similar expressions are intended to identify forward-looking statements. Without limiting the generality of the preceding statement, all statements in this presentation relating to estimated and projected revenue, expectations regarding production capacity, anticipated capital expenditures, expansion, profit, product demand, margins, costs, cash flows, sources of capital, growth rates, potential acquisitions, closing dates for transactions, regulatory approvals, future facility openings, and future financial and operating results are forward-looking statements. We caution investors that any such forward-looking statements are based on the Company's current projections and expectations about future events and financial trends, the receipt of all required regulatory approvals, and on certain assumptions and analysis made by the Company in light of the experience of the Company and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein. Such factors include, among other, the risks and uncertainties identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2021, and in the Company's other reports and filings with the applicable Canadian securities regulators on its profile on SEDAR at www.sedar.com and United States Securities and Exchange Commission ("SEC") on its profile on EDGAR at www.sec.gov. Although the Company believes that any forward-looking statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such statements, there can be no assurance that any such forward-looking statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking statements. Any forward-looking statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this presentation.

To the extent any forward-looking statement in this presentation constitutes "future-oriented financial information" or "financial outlooks" within the meaning of applicable securities laws, such information is being provided for the purpose of providing information about management's current expectations and goals relating to the future of the Company and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such future-oriented financial information and financial outlooks. Future-oriented financial information and financial outlooks, as with forward-looking statements, generally are, without limitation, based on the assumptions and subject to the risks set out above, among others. The Company's actual financial position and results of operations may differ materially from management's current expectations and, as a result, the Company's financial position may differ materially from what is provided in this presentation. Such information is presented for illustrative purposes only and may not be an indication of the Company's actual financial position or results of operations. Any financial outlook or future-oriented financial information, as defined by applicable securities laws, has been approved by management of the Company as of the date hereof and the Company disclaims any obligation to update such outlooks or information, expect as required by applicable securities laws.

OVERVIEW

Vertically integrated operator with assets in Illinois, Michigan, Ohio, Massachusetts, New Jersey, and Pennsylvania.

Owns and operates state-of-the-art cultivation facilities; grows award-winning strains and produces a curated selection of products.

Tickers	CSE: AAWH.U; OTCQX: AAWH
Founded	2018
Headquarters	New York
Employees (as of current)	~2,000
States of Operation	NJ, MI, OH, IL, MA, PA
Dispensaries (as of 1/3/23)	24 open
Cultivation (as of 1/3/23)	6 open

EV1		$573M
Market Cap1		$355M
Revenue(2) /		2020	$144M	/ +1100%
YoY Growth		2021	$332M	/ +131%
		2022E	$402M	/ + 21%
Adj. EBITDA(2)	/	2020	$31M / 21.5%
Margin		2021	$79M / 23.9%
		2022E	$91M

EV /	1.4x
2022E Revenue(2)
EV /	6.3x
2022E Adj. EBITDA(2)
Total Debt,net(3) /	$310M / $91M
Cash

(1)	Market cap equals 195.1 million Fully Diluted Shares Outstanding calculated per treasury share method times 9/30/22 share price of US$1.82 on the CSE.
(2)	Market cap plus ~$219 net debt equals Enterprise Value.
2022 estimates based on consensus as of 11/3/22	3
(3)	Total Debt, net is equal to Total debt less unamortized deferred financing costs.

EXPANDING FOOTPRINT

6 states

24 operating dispensaries

ILLINOIS	NEW JERSEY	MICHIGAN
8 retail	3 retail	7 retail
2 dispensary pending close2	1 cultivation / processing	1 planned retail1
1 cultivation / processing	OHIO	1 cultivation / processing
MASSACHUSETTS	PENNSYLVANIA1
2 medical retail	2 retail
2 retail	3 pending medical retail2	4 planned medical retail licenses1
1 planned retail1	1 cultivation / processing	1 cultivation / processing
1 cultivation / processing

ILLINOIS

MASSACHUSETTS

NEW JERSEY

MICHIGAN

OHIO

PENNSYLVANIA

2020 YE		2021 YE		CURRENT 11/1		2023 EXPECTED BY YE
12 Dispensaries		20 Dispensaries		24 Operating Dispensaries		6 States
74,000 ft2 Canopy		175,000 ft2 Canopy		11 Additional Dispensary		35 Operating Dispensaries(1,2)
				Licenses(1,2)
				245,000 ft2 Canopy

1.	License is owned by AWH, but the site is not yet operational and/or under construction. Includes Century, MI; New Bedford, MA; and 4 Pennsylvania dispensaries.
2.	Includes pending acquisition of Ohio Patient Access LLC (3 OH dispensaries), Homecoming paper IL dispensary license (to be sited in Tinley Park, IL), and InLabs paper IL dispensary license.	4
Note: Timeline illustrative; does not necessarily reflect scale.

ASCEND INVESTMENT THESIS

F O C U S : A C H I E V E S C A L E I N S E L E C T L I M I T E D L I C E N S E M A R K E T S

K E Y F L A G S H I P L O C A T I O N S I N M A R K E T S W I T H H I G H B A R R I E R S T O E N T R Y D I S C I P L I N E D C A P I T A L A L L O C A T I O N ; S U C C E S S F U L E X E C U T I O N O F M & A M A N A G E M E N T W I T H P R O V E N T R A C K R E C O R D O F E X E C U T I O N I N I L

C O N T I N U E D M A R G I N I M P R O V E M E N T A S M O R E A S S E T S A R E " T U R N E D O N " S T R O N G F I N A N C I A L S A N D R E V E N U E G R O W T H

5 5